https://www.selleckchem.com/pr....oducts/Raltitrexed.h
COVID-19 has been giving the devastating impact on the current medical care system. There are quite many guidelines on COVID-19, but only a few on the management of hepatocellular carcinoma (HCC) during COVID-19 pandemic. We develop these recommendations to preserve adequate clinical practice for the management of HCC. Experts of HCC in the Asia-Pacific region exchanged opinions via webinar, and these recommendations were formed. Close contact should be minimized to reduce possible exposure of both medical staff and patients to the
Like
Comment
Share
